Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM). (2023)
Attributed to:
Integrative genomic, epigenetic and functional studies in diabetic kidney disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1681/asn.0000000000000189
PubMed Identifier: 37560967
Publication URI: http://europepmc.org/abstract/MED/37560967
Type: Journal Article/Review
Volume: 34
Parent Publication: Journal of the American Society of Nephrology : JASN
Issue: 10
ISSN: 1046-6673